In order to understand the relationship between the expression of these NER factors and the possibility of developing cisplatin resistance, we evaluated the status of mRNA and protein levels of XPA, XPC, XPF, XPG, ERCC1, and DDB2 in various cisplatin-sensitive and -resistant ovarian cancer cell lines. This evidence concerns the gene ERCC4 and ovarian carcinoma.